Literature DB >> 11461868

Tumor recurrence after radiofrequency thermal ablation of hepatic tumors: spectrum of findings on dual-phase contrast-enhanced CT.

S Chopra1, G D Dodd, K N Chintapalli, J R Leyendecker, O I Karahan, H Rhim.   

Abstract

OBJECTIVE: We conducted this study to determine the spectrum of CT findings of tumor recurrence after radiofrequency ablation of primary and secondary malignant hepatic tumors.
MATERIALS AND METHODS: Twenty-five patients, 10 with hepatocellular carcinoma (HCC) and 15 patients with metastases who developed tumor recurrence after radiofrequency ablation of hepatic neoplasms, formed the study population. Three observers reviewed the CT scans of these patients and evaluated the location (local intrahepatic, remote intrahepatic, or extrahepatic) of all recurrent lesions and the morphology and enhancement characteristics of local intrahepatic recurrences.
RESULTS: Local intrahepatic recurrences were seen in nine patients (90%) and 11 patients (73%); remote intrahepatic recurrences, in five patients (50%) and seven patients (45%); and extrahepatic recurrences, in zero and six patients (40%) with recurrent HCC and recurrent metastases, respectively. Of the 12 nodules of local intrahepatic recurrences in HCC and the 24 in metastases, the patterns of local intrahepatic recurrences were of nodular, halo, and gross enlargement types in eight (67%) and nine (38%), four (33%) and six (38%), and zero and nine (37%) nodules in HCC and hepatic metastases, respectively. The number of local intrahepatic recurrent lesions enhancing in the arterial phase was significantly greater in HCC.
CONCLUSION: Tumor recurrences occurred at intra- and extrahepatic sites after radiofrequency ablation of hepatic neoplasms. The local intrahepatic recurrences appeared in three patterns: nodular, halo, or gross enlargement. The sites of recurrence and the morphologic patterns of local intrahepatic tumor recurrence differed between primary and secondary hepatic neoplasms.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11461868     DOI: 10.2214/ajr.177.2.1770381

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  16 in total

1.  Guidance and control of percutaneous treatments with contrast-enhanced ultrasound.

Authors:  L Solbiati; T Ierace; M Tonolini; L Cova
Journal:  Eur Radiol       Date:  2003-11       Impact factor: 5.315

Review 2.  Image-guided tumor ablation: standardization of terminology and reporting criteria.

Authors:  S Nahum Goldberg; Clement J Grassi; John F Cardella; J William Charboneau; Gerald D Dodd; Damian E Dupuy; Debra Gervais; Alice R Gillams; Robert A Kane; Fred T Lee; Tito Livraghi; John McGahan; David A Phillips; Hyunchul Rhim; Stuart G Silverman
Journal:  Radiology       Date:  2005-04-21       Impact factor: 11.105

3.  Analysis of iodinated contrast delivered during thermal ablation: is material trapped in the ablation zone?

Authors:  Po-Hung Wu; Chris L Brace
Journal:  Phys Med Biol       Date:  2016-07-25       Impact factor: 3.609

4.  Effect of radiofrequency ablation of the liver on cell-mediated immunity in rats.

Authors:  Hee Chul Yu; Jang Il Moon; Zhe-Wu Jin; Dae Yung Lee; Chan Young Kim; Chang Ho Song; Baik Hwan Cho
Journal:  World J Surg       Date:  2005-06       Impact factor: 3.352

5.  Do liposomal apoptotic enhancers increase tumor coagulation and end-point survival in percutaneous radiofrequency ablation of tumors in a rat tumor model?

Authors:  Wei Yang; Muneeb Ahmed; Mostafa Elian; El-Shymma A Hady; Tatyana S Levchenko; Rupa R Sawant; Sabina Signoretti; Michael Collins; Vladimir P Torchilin; S Nahum Goldberg
Journal:  Radiology       Date:  2010-09-21       Impact factor: 11.105

Review 6.  Radiofrequency ablation of cancer.

Authors:  Marc Friedman; Igor Mikityansky; Anthony Kam; Steven K Libutti; McClellan M Walther; Ziv Neeman; Julia K Locklin; Bradford J Wood
Journal:  Cardiovasc Intervent Radiol       Date:  2004-06-03       Impact factor: 2.740

7.  Open surgical is superior to percutaneous access for radiofrequency ablation of hepatic metastases.

Authors:  Robert M Eisele; Ulf Neumann; Peter Neuhaus; Guido Schumacher
Journal:  World J Surg       Date:  2009-04       Impact factor: 3.352

8.  Radiofrequency ablation combined with KS-IL2 immunocytokine (EMD 273066) results in an enhanced antitumor effect against murine colon adenocarcinoma.

Authors:  Erik E Johnson; Brett H Yamane; Ilia N Buhtoiarov; Hillary D Lum; Alexander L Rakhmilevich; David M Mahvi; Stephen D Gillies; Paul M Sondel
Journal:  Clin Cancer Res       Date:  2009-07-28       Impact factor: 12.531

9.  Three-dimensional quantitative assessment of ablation margins based on registration of pre- and post-procedural MRI and distance map.

Authors:  Soichiro Tani; Servet Tatli; Nobuhiko Hata; Xavier Garcia-Rojas; Olutayo I Olubiyi; Stuart G Silverman; Junichi Tokuda
Journal:  Int J Comput Assist Radiol Surg       Date:  2016-04-02       Impact factor: 2.924

Review 10.  Post-treatment imaging of liver tumours.

Authors:  Wolfgang Schima; Ahmed Ba-Ssalamah; Amir Kurtaran; Martin Schindl; Thomas Gruenberger
Journal:  Cancer Imaging       Date:  2007-10-01       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.